|
Muscle disease
Citations 71-80 of 283 total displayed.
|
Past content
(since Jan 2001):
|
- EDITORIALS
Enzyme replacement for infantile Pompe disease: The first step toward a cure
- Kathryn R. Wagner
Neurology 2007; 68: 88-89.
[Full text]
[PDF]
- ARTICLES
Recombinant human acid -glucosidase: Major clinical benefits in infantile-onset Pompe disease
- P. S. Kishnani, D. Corzo, M. Nicolino, B. Byrne, H. Mandel, W. L. Hwu, N. Leslie, J. Levine, C. Spencer, M. McDonald, J. Li, J. Dumontier, M. Halberthal, Y. H. Chien, R. Hopkin, S. Vijayaraghavan, D. Gruskin, D. Bartholomew, A. van der Ploeg, J. P. Clancy, R. Parini, G. Morin, M. Beck, G. S. De la Gastine, M. Jokic, B. Thurberg, S. Richards, D. Bali, M. Davison, M. A. Worden, Y. T. Chen, and J. E. Wraith
Neurology 2007; 68: 99-109.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Broad spectrum of Pompe disease in patients with the same c.-32-13T G haplotype
- M. A. Kroos, R. J. Pomponio, M. L. Hagemans, J.L.M. Keulemans, M. Phipps, M. DeRiso, R. E. Palmer, M. G.E.M. Ausems, N. A.M.E. Van der Beek, O. P. Van Diggelen, D. J.J. Halley, A. T. Van der Ploeg, and A. J.J. Reuser
Neurology 2007; 68: 110-115.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys
- Rita Horvath, Rudolf Andre Kley, Hanns Lochmüller, and Matthias Vorgerd
Neurology 2007; 68: 56-58.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Endurance training: An effective and safe treatment for patients with LGMD2I
- M. -L. Sveen, T. D. Jeppesen, S. Hauerslev, T. O. Krag, and J. Vissing
Neurology 2007; 68: 59-61.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Muscle imaging in dominant core myopathies linked or unlinked to the ryanodine receptor 1 gene
- D. Fischer, M. Herasse, A. Ferreiro, H. M. Barragán-Campos, J. Chiras, L. Viollet, S. Maugenre, J. -P. Leroy, N. Monnier, J. Lunardi, P. Guicheney, M. Fardeau, and N. B. Romero
Neurology 2006; 67: 2217-2220.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Ptosis as a feature of late-onset glycogenosis type II
- W. B. Groen, W. G. Leen, A.M.C. Vos, J. R.M. Cruysberg, P. A. van Doorn, and B. G.M. van Engelen
Neurology 2006; 67: 2261-2262.
[Full text]
[PDF]
- ARTICLES
Mitochondrial disease criteria: Diagnostic applications in children
- E. Morava, L. van den Heuvel, F. Hol, M. C. de Vries, M. Hogeveen, R. J. Rodenburg, and J.A.M. Smeitink
Neurology 2006; 67: 1823-1826.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Pregnancy and birth outcomes in women with facioscapulohumeral muscular dystrophy
- E. Ciafaloni, E. K. Pressman, A. M. Loi, A. M. Smirnow, D. J. Guntrum, N. Dilek, and R. Tawil
Neurology 2006; 67: 1887-1889.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Early development of critical illness myopathy and neuropathy in patients with severe sepsis
- Jaffar Khan, Taylor B. Harrison, Mark M. Rich, and Marc Moss
Neurology 2006; 67: 1421-1425.
[Abstract]
[Full text]
[PDF]
|
|